Cargando…

IFN-α(2b) reduces released particles of Human T-lymphotropic Virus-I from HTLV-I transformed cell line

Detalles Bibliográficos
Autores principales:	Hartoonian, Christine, Rasekhian, Mahsa, Edalat, Rozita, Arashkia, Arash, Azadmanesh, Kayhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236918/ http://dx.doi.org/10.1186/1742-4690-8-S2-P30

Ejemplares similares

In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines
por: Shayan, Sara, et al.
Publicado: (2023)

An Enterovirus-Like RNA Construct for Colon Cancer Suicide Gene Therapy
por: Rasekhian, Mahsa, et al.
Publicado: (2015)

Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?
por: Shayan, Sara, et al.
Publicado: (2022)

Human T-Lymphotropic Virus (HTLV) Type I in vivo Integration in Oral Keratinocytes
por: Domínguez, Martha C., et al.
Publicado: (2011)

Medical conditions, social and neurological patients of the T-lymphotropic virus humanities-HTLV I
por: Gaspar, GLC, et al.
Publicado: (2014)

Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
por: Shayan, Sara, et al.
Publicado: (2022)

Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy
por: Fukui, Shoichi, et al.
Publicado: (2017)

Human T Lymphotropic Virus Type I (HTLV-I) is a Risk Factor for Coronary Artery Disease
por: Farid Hosseni, Reza, et al.
Publicado: (2013)

Antibodies against p40(tax) Gene Product of Human T‐Lymphotropic Virus Type‐I (HTLV‐I) under Various Conditions of HTLV‐I Infection
por: Kamihira, Shimeru, et al.
Publicado: (1989)

Isolation, cloning, and expression of E. coli BirA gene for biotinylation applications
por: Etemadzadeh, Mohammad Hossein, et al.
Publicado: (2015)

Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)–infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I–uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1
por: Moriuchi, Hiroyuki, et al.
Publicado: (1998)

Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients
por: Vakili, Rosita, et al.
Publicado: (2013)

A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice
por: Motavalli Khiavi, Farhad, et al.
Publicado: (2018)

Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses
por: Shoushtari, Mohammad, et al.
Publicado: (2022)

Fiber manipulation and post-assembly nanobody conjugation for adenoviral vector retargeting through SpyTag-SpyCatcher protein ligation
por: Kadkhodazadeh, Maryam, et al.
Publicado: (2022)

Adult T-Cell Lymphoma (ATL) With Erythroderma in Indolent Human T-Lymphotropic Virus Type I (HTLV-1) Infection
por: Qasim, Abeer, et al.
Publicado: (2023)

Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies
por: Khiavi, Farhad Motavalli, et al.
Publicado: (2017)

Is there any Association Between Human Lymphotropic Virus Type I (HTLV-I) Infection and Systemic Lupus Erythematosus? An Original Research and Literature Review
por: Shirdel, Abbas, et al.
Publicado: (2013)

HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012)
por: GONZÁLEZ-ALCAIDE, Gregorio, et al.
Publicado: (2016)

Designing a Human T-Lymphotropic Virus Type 1 (HTLV-I) Diagnostic Model using the Complete Blood Count
por: Sarbaz, Masoumeh, et al.
Publicado: (2013)

A novel medium-throughput biological assay system for HTLV-1 infectivity and drug discovery
por: Abdizadeh, Mojtaba Fattahi, et al.
Publicado: (2017)

Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL)
por: Ahmadi Ghezeldasht, Sanaz, et al.
Publicado: (2013)

Expression of a biotin acceptor peptide-containing protein with potential incorporation on the lentiviral envelope as a viral surface engineering platform
por: Etemadzadeh, Mohammad Hossein, et al.
Publicado: (2015)

The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options
por: Beig Parikhani, Arezoo, et al.
Publicado: (2021)

Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
por: Araya, Natsumi, et al.
Publicado: (2011)

Cellular tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2)
por: Kannian, Priya, et al.
Publicado: (2011)

Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors
por: Hedayati-Moghaddam, Mohammad Reza, et al.
Publicado: (2015)

Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
por: Kannian, Priya, et al.
Publicado: (2010)

Epidemiology of Human T-cell lymphotropic viruses (HTLV) in England and Wales, 2003-2012
por: Croxford, Sara E, et al.
Publicado: (2014)

Seroepidemiology of Human T-Cell Lymphotropic Virus Type-1 (HTLV1) in Mashhad
por: Safabakhsh, Hamidreza, et al.
Publicado: (2014)

The role of human T-lymphotropic virus (HTLV) in cardiovascular diseases: A review of literature
por: Abolbashari, Samaneh, et al.
Publicado: (2018)

Human T-lymphotropic viruses (HTLV) in England and Wales, 2004 to 2013: testing and diagnoses
por: Ireland, Georgina, et al.
Publicado: (2017)

Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1)
por: Raza, Md. Thosif, et al.
Publicado: (2021)

HTLV‐I Uveitis: A Distinct Clinical Entity Caused by HTLV‐I
por: Mochizuki, Manabu, et al.
Publicado: (1992)

Histopathologic differences between human T-lymphotropic virus type 1 (HTLV-1)-positive and HTLV-1-negative polymyositis
por: Abdullah, Hazem M, et al.
Publicado: (2011)

Provirus Mutations of Human T-Lymphotropic Virus 1 and 2 (HTLV-1 and HTLV-2) in HIV-1-Coinfected Individuals
por: Campos, Karoline Rodrigues, et al.
Publicado: (2020)

Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa
por: Calattini, Sara, et al.
Publicado: (2005)

Phylogeography of Human T-lymphotropic Virus Type 1 (HTLV-1) Lineages Endemic to Japan
por: Otani, Masashi, et al.
Publicado: (2012)

Distribution of Human T-Lymphotropic Virus (HTLV) and Hepatitis C Co-infection in Bahia, Brazil
por: Pereira, Felicidade Mota, et al.
Publicado: (2020)

Editorial: Prevention and control of human T lymphotropic viruses 1 and 2 (HTLV-1/2)
por: Machado, Luiz Fernando Almeida, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cf13vku2t9uqrlhpr3vs821g1u